Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
AKLIEF (Galderma Australia Pty Ltd)
Product name
AKLIEF
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
166 (175 working days)
Active ingredients
trifarotene
Registration type
NCE/NBE
Indication
AKLIEF (cream) is indicated for the topical treatment of Acne Vulgaris of the face and/or the trunk in patients from 12 years of age and older, when many comedones, papules and/or pustules are present.